RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Treatment of recurrent corneal erosion and corneal edema with topical osmotic colloidal solution.

Ophthalmology 1981 August
Ten patients with recurrent corneal erosion unresponsive to conventional therapy were treated with a topical colloidal solution to obtain epithelial dehydration and lubrication. Nine of the ten patients responded with improved vision and resolution of symptoms. All erosions healed and focal epithelial abnormalities were decreased or reversed. Similar treatment of ten patients with corneal edema due to endothelial decompensation did not significantly reduce symptoms or improve vision, but such a solution may have significant dehydrating effect when edema results solely from epithelial abnormalities. Pachometric studies of the cornea demonstrated no significant change in stromal thickness during therapy. Colloidal hyperosmotic solutions are well tolerated and appear effective in treating recurrent corneal erosion.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app